• FirefoxInstall the new Firefox »
  •  Dow Down0.06% Nasdaq Up0.42%

    Pernix Therapeutics Holdings, Inc. (PTX)

    -NasdaqGM
    10.90 Up 0.56(5.42%) Feb 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 84,872   61,313   60,607  
    Cost of Revenue43,870  23,377  20,921  
    Gross Profit 41,002   37,936   39,686  
    Operating Expenses
    Research Development4,798  732  922  
    Selling General and Administrative62,551  35,452  22,158  
    Non Recurring -   -   -  
    Others8,676  3,201  2,303  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (54,661) (1,689) 13,108  
    Income from Continuing Operations
    Total Other Income/Expenses Net(7,320) -  (380)
    Earnings Before Interest And Taxes(42,343)(1,689)13,108  
    Interest Expense4,049  95  171  
    Income Before Tax(46,391)(1,784)12,937  
    Income Tax Expense(20,756)(374)4,589  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(25,635)(1,650)7,533  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (25,635) (1,410) 8,348  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (25,635) (1,410) 8,348  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.